Archive for the ‘Food Safety News’ category

FDA requiring lower starting dose for sleep drug Lunesta

May 16, 2014

The U.S. Food and Drug Administration today announced it required the manufacturer of the sleep drug Lunesta (eszopiclone) to change the drug label and lower the current recommended starting dose. Data show that eszopiclone levels in some patients may be high enough the morning after use to impair activities that require alertness, including driving, even […]

FDA allows marketing of first prosthetic arm that translates signals from person’s muscles to perform complex tasks

May 13, 2014

The U.S. Food and Drug Administration (FDA) today allowed marketing of the DEKA Arm System, the first prosthetic arm that can perform multiple, simultaneous powered movements controlled by electrical signals from electromyogram (EMG) electrodes.

Strong America Limited ISSUES ALLERGY ALERT ON UNDECLARED EGG IN “Golden Smell Hotpot Meat Ball Medley”

May 12, 2014

Strong America Limited of Long Island City, New York is recalling its 1 pound package of “Golden Smell Hotpot Meat Ball Medley” food treats because they may contain undeclared eggs. Read The Complete Story!

FDA allows marketing of first prosthetic arm that translates signals from person’s muscles to perform complex tasks

May 10, 2014

The U.S. Food and Drug Administration (FDA) today allowed marketing of the DEKA Arm System, the first prosthetic arm that can perform multiple, simultaneous powered movements controlled by electrical signals from electromyogram (EMG) electrodes.

FDA approves Zontivity to reduce the risk of heart attacks and stroke in high-risk patients

May 9, 2014

The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore the blood flow to the heart in patients with a previous heart attack or blockages in the arteries to the legs.

STE Fromagere Du Livradois Voluntarily Recalls Raclette Cheese and Montboissie Cheese for Possible Health Risk

May 8, 2014

Ste Fromagere du Livradois of Fournols, France is recalling Haut Livradois brand Raclette and Montboissie cheeses lot#350 because they have the potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Read The Complete Story!

Sixdog Investments Voluntarily Recalls Eggs Because of Possible Health Risk

May 5, 2014

Sixdog Investments, LLC is voluntarily recalling some cases of their certified organic eggs, because of the potential they are contaminated with Salmonella. This voluntary field action was initiated because of routine testing results, and not because of illness to date from consumption. Read The Complete Story!

NOH Foods Of Hawaii Issues Allergy Alert On Undeclared Milk In Hawaiian Coconut Pudding Haupia (LUAU Dessert)

May 1, 2014

NOH FOODS OF HAWAII, of Honolulu, HI and Gardena, CA is voluntarily recalling its 2 ounce, 4 ounce, and 3 lb. (48 oz) packages of “Hawaiian Coconut Pudding” because they may contain undeclared dairy product. Read The Complete Story!

United States enters consent decree with New York cheese producer due to Listeria contamination

April 29, 2014

On April 28, 2014, United States District Court Judge Richard J. Arcara of the Western District of New York entered a consent decree of permanent injunction between the United States and Finger Lakes Farmstead Cheese Company, LLC, of Trumansburg, N.Y. and its co-owner Nancy Taber Richards. The consent decree was pursued by the U.S. Attorney’s […]

FDA issues proposals to address risks associated with surgical mesh for transvaginal repair of pelvic organ prolapse

April 29, 2014

The U.S. Food and Drug Administration today issued two proposed orders to address the health risks associated with surgical mesh used for transvaginal repair of pelvic organ prolapse (POP). If finalized, the orders would reclassify surgical mesh for transvaginal POP from a moderate-risk device (class II) to a high-risk device (class III) and require manufacturers […]

FDA approves Zykadia for late-stage lung cancer

April 29, 2014

The U.S. Food and Drug Administration today granted accelerated approval to Zykadia (ceritinib) for patients with a certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC).

FDA approves first human papillomavirus test for primary cervical cancer screening

April 25, 2014

The U.S. Food and Drug Administration today approved the first FDA-approved HPV DNA test for women 25 and older that can be used alone to help a health care professional assess the need for a woman to undergo additional diagnostic testing for cervical cancer. The test also can provide information about the patient’s risk for […]

FDA approves Sylvant for rare Castleman’s disease

April 24, 2014

The U.S. Food and Drug Administration today approved Sylvant (siltuximab) to treat patients with multicentric Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the lymph nodes).

FDA proposes to extend its tobacco authority to additional tobacco products, including e-cigarettes

April 24, 2014

As part of its implementation of the Family Smoking Prevention and Tobacco Control Act signed by the President in 2009, the U.S. Food and Drug Administration today proposed a new rule that would extend the agency’s tobacco authority to cover additional tobacco products.

FDA proposes new expedited access program for medical devices that address unmet medical needs

April 23, 2014

Today, the U.S. Food and Drug Administration proposed a new program to provide earlier access to high-risk medical devices that are intended to treat or diagnose patients with serious conditions whose medical needs are unmet by current technology.

FDA approves Cyramza for stomach cancer

April 22, 2014

The U.S. Food and Drug Administration today approved Cyramza (ramucirumab) to treat patients with advanced stomach cancer or gastroesophageal junction adenocarcinoma, a form of cancer located in the region where the esophagus joins the stomach.

FDA approves Ragwitek for short ragweed pollen allergies

April 17, 2014

The U.S. Food and Drug Administration today approved Ragwitek, the first allergen extract administered under the tongue (sublingually) to treat short ragweed pollen induced allergic rhinitis (hay fever), with or without conjunctivitis (eye inflammation), in adults 18 years through 65 years of age.

FDA discourages use of laparoscopic power morcellation for removal of uterus or uterine fibroids

April 17, 2014

In a safety communication notice issued today, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond […]

Puerto Rico bakery agrees to stop manufacturing and distributing products

April 16, 2014

Los Genuinos, Inc., a Bayamon, Puerto Rico, food manufacturer, has agreed under terms of a court order not to process or distribute food until it addresses the unsanitary conditions found by U.S. Food and Drug Administration investigators. The company must also correct its product labels to accurately reflect the ingredients used in its products.

Home | Copyright 2008-2024 FoodandDrugRecall.org